drugset / Trial / NCT01593644

Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler

NCT01593644

Phase 2 Unknown 75 enrolled Adenobio N.V
NaSingle-groupSingle-blind

Summary

The purpose of this study is to evaluate the efficacy and tolerance of a dipyridamole/adenosine combination given intravenously, as a slow bolus and at low doses to adenosine alone (given at its recommended dosage adjusted to patients' weight) for coronary flow reserve assessment (in 60-75 patients with stable ischemic heart disease) using transthoracic echodoppler

Timeline

Start
2011-06
Primary completion
2013-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Adenosine Small molecule 6 mg Intravenous
Subject Dipyridamole Other / unclassified 10 mg Intravenous

Indications